Author(s)

M. Piras, I. N. Fleming, W. T. A. Harrison, M. Zanda

ISBN

0936-5214

Publication year

2012

Periodical

Synlett

Periodical Number

20

Volume

Pages

2899-2902

Author Address

Zanda, M Univ Aberdeen, Kosterlitz Ctr Therapeut, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland Univ Aberdeen, Kosterlitz Ctr Therapeut, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland Univ Aberdeen, Dept Chem, Aberdeen AB24 3UE, Scotland

Full version

The Arg-Gly-Asp (RGD) tripeptide is the smallest recognition sequence for the alpha(v)beta(3) integrin receptor. A number of non-peptide analogues of the RGD linear sequence, some of them having improved pharmacological properties, have been proposed in the last two decades. In this study, the stereogenic trifluoroethylamine function was employed as peptide bond surrogate for the development of a new class of RGD peptide mimics. In fact, the trifluoroethylamine group was shown to behave as a peptide-bond surrogate maintaining the H-bond donor capacity of the NH peptide group and a CH(CF3)NH backbone angle close to the native peptide bond 120 degrees. The trifluoroethylamine function is also known to display high metabolic stability and in some cases it positively affects ligand-receptor interactions. Two linear Psi[CH(CF3)NH]Gly-RGD diastereoisomers were synthesized with good stereocontrol and submitted to biological assays. A remarkable loss in alpha(v)beta(3) integrin affinity was observed for both compounds, suggesting that the bulky CF3 moiety is not well tolerated within the alpha(v)beta(3) binding pocket.